FRIDAY, Oct. 11, 2024 (HealthDay News) — Facing a nationwide shortage of vital IV fluids after Hurricane Helene knocked out a North Carolina production plant, officials heaved a sigh of […]
FRIDAY, Oct. 11, 2024 (HealthDay News) — Facing a nationwide shortage of vital IV fluids after Hurricane Helene knocked out a North Carolina production plant, officials heaved a sigh of relief at the news that a second plant in Daytona Beach, Fla., was spared by Hurricane Milton and remains functional.
According to the New York Times, a spokeswoman for B. Braun, the company that runs the Daytona Beach plant, said the facility remained intact and would reopen on Friday.
Between them, the North Carolina and Florida plants produce 60% and 25%, respectively, of the IV fluids that many patients in hospitals and dialysis centers need to survive.
With supplies already crippled by the closure of Baxter”s Marion, NC, plant after Helene, the closure of the B. Braun facility would have been devastating, experts said.
IV fluids are needed for the care of patients such as premature babies, people on dialysis and frail individuals who rely on IV feeding.
Hospitals across the United States are already postponing surgeries and rationing IV fluids as shortages take hold, the Times said.
Hannah Hale, 37, lives near Dallas and for eight years has required IV feeding with a concentrated dextrose solution, after Crohn”s disease led to surgeries that impaired her digestive tract.
Her specialized pharmacy told her on Monday it cannot find enough of the IV solution to replenish her supply.
“They’re not supposed to just drop me like that,” she told the Times, adding that calls to 14 other pharmacies failed to find a new supplier.
“I don’t have any recourse,” Hale said.
Anticipating Milton, B. Braun had told the Times that on Tuesday it had loaded trucks headed north full of products, to get them to a safer location.
At Baxter, staff have been working overtime to help patch together new supply chains, increasing production at plants located overseas.
On Wednesday, the U.S. Food and Drug Administration (FDA) said that it was authorizing imports of IV products from Baxter plants in Canada, Ireland, the United Kingdom and China.
Baxter had been forced to limit supplies to hospitals to 40% of usual following the damage to its plant by Helene, but the company told the Times that deliveries would have already risen to about 60% of usual by Wednesday of this week.
Baxter would not say when it expected its Marion plant to become fully operational again, but said it hoped to resume production in phases by the end of the year.
A bridge near the plant is being prioritized for repair so that trucks already loaded with Baxter product can leave and distribute supplies not damaged by the storm, the Times said.
“We will spare no resource — human or financial — to restart operations and help ensure patients and providers have the products they need,” José Almeida, the chief executive at Baxter, said in a statement Wednesday.
Hospitals across the nation need IV fluids to hydrate and feed patients, including those battling a life-threatening blood infection known as sepsis.
Emergency Diagnosis Linked to Worse Outcomes for Range of Conditions
Small Change in Hours Benefits Emergency Physicians Working Night Shifts
ED Boarding Time Varies Considerably Across Hospitals
Warning Symptoms, Clinical History Can Predict Sudden Cardiac Arrest
2011 to 2021 Saw Heart Failure-Related Hospitalization Rise in CKD
Machine Learning Model IDs Heart Failure With Reduced Ejection Fraction Using Routine Lab Indicators
Addition of CAC to PREVENT-ASCVD Equations May Improve Predictive Utility in Certain Patients
Central Adiposity Reclassifies Cardiovascular Risk Across BMI Spectrum